Condensed Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Feb. 05, 2023		304,076
Beginning balance at Feb. 05, 2023	$ 941,233	$ 30	$ 2,493,769	$ (15,504)	$ (1,537,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		790
Issuance of common stock upon exercise of stock options	4,619		4,619
Stock-based compensation expense	78,665		78,665
Vesting of restricted stock units (in shares)		3,670
Vesting of restricted stock units	0	$ 1	(1)
Tax withholding on vesting of restricted stock units (in shares)		(281)
Tax withholding on vesting of restricted stock units	(6,759)		(6,759)
Common stock issued under employee stock purchase plan (in shares)		1,069
Common stock issued under employee stock purchase plan	21,219		21,219
Repurchase of common stock (in shares)		(2,872)
Repurchases of common stock	(69,911)		(69,911)
Issuance of common stock upon conversion of convertible senior notes (in shares)		1
Issuance of common stock upon conversion of convertible senior notes	(456)		(456)
Other comprehensive income (loss)	4,598			4,598
Net loss	(67,401)				(67,401)
Ending balance (in shares) at May. 07, 2023		306,453
Ending balance at May. 07, 2023	905,807	$ 31	2,521,145	(10,906)	(1,604,463)
Beginning balance (in shares) at Feb. 04, 2024		319,523
Beginning balance at Feb. 04, 2024	1,270,094	$ 32	2,749,595	(3,782)	(1,475,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,034
Issuance of common stock upon exercise of stock options	13,223		13,223
Stock-based compensation expense	114,617		114,617
Vesting of restricted stock units (in shares)		3,679
Vesting of restricted stock units	0	$ 1	(1)
Tax withholding on vesting of restricted stock units (in shares)		(250)
Tax withholding on vesting of restricted stock units	(12,478)		(12,478)
Common stock issued under employee stock purchase plan (in shares)		1,195
Common stock issued under employee stock purchase plan	25,328		25,328
Other comprehensive income (loss)	(1,802)			(1,802)
Net loss	(35,009)				(35,009)
Ending balance (in shares) at May. 05, 2024		325,181
Ending balance at May. 05, 2024	$ 1,373,973	$ 33	$ 2,890,284	$ (5,584)	$ (1,510,760)